AlphaYou
Overview
Smart money at a glance
Filings to Oct 13, 2026Net buying: insiders sold $0 and bought $215K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$215K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 13- Open
- $1.35
- 52-wk high
- $2.33
- High
- $1.44
- 52-wk low
- $0.58
- Low
- $1.35
- Prev close
- $1.33
- Mkt cap
- $7.5M
- Volume
- 56.1K
- Beta
- 0.93
- P/S
- 0.9x
- P/B
- 7.0x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -156.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about INM filings
Are insiders buying or selling InMed Pharmaceuticals Inc (INM) stock?
Net buying: insiders sold $0 and bought $215K of INM stock on the open market in the 90 days to Oct 13, 2026, according to SEC Form 4 filings. The largest was Adar1 Capital Management, LLC (10% owner), who bought $191K. The latest filing was on Oct 8, 2026.
Which members of Congress have traded INM recently?
None. No member of Congress disclosed a INM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this INM smart-money data?
This summary uses filings available on Oct 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
1 fund holds a position and insiders have been net buying.
What insiders are doing
Buys (3)
- AC
Adar1 Capital Management, Llc
$14K
bought
- AC
Adar1 Capital Management, Llc
$57K
bought
- AC
Adar1 Capital Management, Llc
$118K
bought
How top traders are positioned
No tracked top-trader positions in INM right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No earnings history.
Reports Nov 5, 2026, in 23 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $7M
Valuation
- P/S0.89
- P/B7.05
Quality
- Operating margin0.0%
- ROE-156.8%
- ROA-66.5%
Growth
- Beta0.93
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
65 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace